Endovia Health Sciences vs Epsium Enterprise
Epsium Enterprise is the larger business, with $5.1m of revenue in fiscal 2025 against $73,066 for Endovia Health Sciences (70.0 times as much). Epsium Enterprise grew faster (-59.1% against -90.9%). Epsium Enterprise kept more of each dollar of sales as profit: a net margin of -29.3% against -34537.0%.
| Latest fiscal year | Endovia Health SciencesEDVA, 2025 | Epsium EnterpriseEPSM, 2025 |
|---|---|---|
| Revenue | $73,066 | $5.1m |
| Revenue growth | -90.9% | -59.1% |
| Net income | −$25.2m | −$1.5m |
| Operating margin | — | -29.2% |
| Net margin | -34537.0% | -29.3% |
| Return on equity | — | -15.3% |
| Free cash flow | −$4.8m | −$2.4m |
| Cash | $281,435 | $2.0m |
| Total debt | $6.2m | $0 |
| Debt to equity | — | 0.0% |
| Dividend per share | — | — |
| Dividend yield | — | — |
| Share buybacks | — | $300,000 |
| Employees | — | — |
| Market value | $134,451 | $2.3m |
| Price vs our value range | — | — |
| Moat score | 25 (Weak) | — |
| Insider trades, 12 months | 0 buys, 0 sales | 0 buys, 0 sales |